Vascular Closure Systems Inc (VCS) is a medical device company that manufactures and commercializes vascular access closure technology for interventional cardiology market. The company is currently securing funding to complete regulatory and clinical requirements to facilitate commercialization of its advanced vascular access closure technology. It also has completed clinical trial of bioabsorbable vascular access closure system. The company operates in Austria, Belgium, Canada, the Czech Republic, Egypt, Holland, Italy, Japan, South Korea, Luxembourg, Portugal, Saudi Arabia, South Africa, Spain, Slovakia, Switzerland, Turkey and the UAE. VCS is headquartered in Las Vegas, Nevada, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vascular Closure Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Vascular Closure Systems Inc Company Overview
- Vascular Closure Systems Inc Company Snapshot
- Vascular Closure Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vascular Closure Systems Inc - Pipeline Analysis Overview
- Vascular Closure Systems Inc - Key Facts
- Vascular Closure Systems Inc - Major Products and Services
- Vascular Closure Systems Inc Pipeline Products by Development Stage
- Vascular Closure Systems Inc Pipeline Products Overview
- FastSeal Bioabsorbable Vascular Access Closure System
- FastSeal Bioabsorbable Vascular Access Closure System Product Overview
- FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr
- FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr Product Overview
- FastSeal Self - Closing Nitinol Clip System
- FastSeal Self - Closing Nitinol Clip System Product Overview
- FastSeal Swellable And Bioabsorbable Tubular Plug System
- FastSeal Swellable And Bioabsorbable Tubular Plug System Product Overview
- RF Thermal Closure System
- RF Thermal Closure System Product Overview
- Vascular Closure Systems Inc - Key Competitors
- Vascular Closure Systems Inc - Key Employees
- Vascular Closure Systems Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Vascular Closure Systems Inc, Recent Developments
- Oct 06, 2014: Vascular Closure Systems announces upcoming CE Mark of Fastseal Bioabsorbable Vascular Access Closure System
- Dec 04, 2012: Vascular Closure Announces Successful Completion Of FIH Clinical Trial Of 6 Fr. / 7 Fr. FastSeal Bioabsorbable Vascular Access Closure System
- Jun 29, 2012: Vascular Closure’s FastSeal Bioabsorbable Vascular Access Closure System Demonstrates 100% Success Rate In 30-Day Follow-Up Results Of Phase I Study
- May 08, 2012: Vascular Closure Systems Announces Conclusion Of Phase I Of FIH Use Of FastSeal Bioabsorbable Vascular Access Closure System
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Vascular Closure Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vascular Closure Systems Inc Pipeline Products by Equipment Type
- Vascular Closure Systems Inc Pipeline Products by Indication
- Vascular Closure Systems Inc, Key Facts
- Vascular Closure Systems Inc, Major Products and Services
- Vascular Closure Systems Inc Number of Pipeline Products by Development Stage
- Vascular Closure Systems Inc Pipeline Products Summary by Development Stage
- FastSeal Bioabsorbable Vascular Access Closure System - Product Status
- FastSeal Bioabsorbable Vascular Access Closure System - Product Description
- FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr - Product Status
- FastSeal Bioabsorbable Vascular Access Closure System - 18 Fr - Product Description
- FastSeal Self - Closing Nitinol Clip System - Product Status
- FastSeal Self - Closing Nitinol Clip System - Product Description
- FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Status
- FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Description
- RF Thermal Closure System - Product Status
- RF Thermal Closure System - Product Description
- Vascular Closure Systems Inc, Key Employees
- Glossary
List of Figures
- Vascular Closure Systems Inc Pipeline Products by Equipment Type
- Vascular Closure Systems Inc Pipeline Products by Development Stage 9
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AccessClosure, Inc.
- Cardiva Medical Inc
- Abbott Vascular Inc
